$NBIO #OTCQB Nascent Biotech Inc. (NBIO: OTCQB) | NascentBiotech’s Independent Consultants Have Begun Research on Pribumumab as a Potential Therapeutic Agent Against (Coronavirus) Covid-19
Copyright 2019 – OTC Markets Group Inc.

News Link